Key Insights

Highlights

Treatment Research

4 treatments under study, led by Radiofrequency Ablation

Research Leaders

5 sponsors active, led by Euraxi Pharma

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Unknown2
Recruiting1

Clinical Trials (3)

Showing 3 of 3 trials
NCT07629843RecruitingPrimary

Patient Satisfaction, Safety, and Efficacy of Endovenous Laser Treatment for Saphenous Veins and Varicose Veins

NCT05099861UnknownPrimary

Clinical Anatomy of Superficial Veins of Lower Limbs

NCT03293836Not ApplicableUnknown

Venous Ulcer: Endovenous Radiofrequency Treatment Trial

Showing all 3 trials

Research Network

Common Treatments

  • Radiofrequency Ablation1
  • Endovenous Laser Ablation Of The Primary Or Recurrent Saphenous Vein1
  • Multilayer Compressive Bandage1
  • No Intervention1

Active Sponsors

  • Euraxi Pharma1
  • Fundação de Amparo à Pesquisa do Estado de São Paulo1
  • Juliana Puggina1
  • Charles University, Czech Republic1
  • GCS Ramsay Santé pour l'Enseignement et la Recherche1

Top Investigators

Related Conditions

  • Varicose Veins Of Lower Limb1
  • Varicose Ulcer1

Activity Timeline